Delivery Order SPE2DB20D2014-SPE2DB25FB51Z

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,937.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of November 4, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a $25,263.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used for diabetes management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a $6,039.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 29, 2025. While this is a standalone delivery order, AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $12,571.77 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a period of performance through June 2024. While the original solicitation is not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,680.81 contract is for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of October 6, 2023 and there is no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,015.98 and has an ultimate completion date of November 15, 2024. The contract provides for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a $35,154.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used for diabetes management. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a $6,006.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used for diabetes management. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. This contract is not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a $14,531.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has a completion date of December 18, 2023 and was awarded on December 15, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a $11,989.47 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB51Z
    Delivery Order

This is a $6,121.56 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen, a medication used to treat diabetes. The contract has a completion date of April 3, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations.

Generated 7/2/25, 11:05 PM